retatrutide drops Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide clinical trial done! Now
Description
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, et al
Millennials are reporting effects that have nothing to do with food: Doomscrolling
The cardiovascular benefits of GLP-1s and GIPs may be independent of improvements in glycemic control, and in part be driven by reduction in inflammation, a key driver of arterial plaque formation
Summary Here, we presented a case study of the various drug delivery strategies that have been applied to extend circulation the half-life of labile GLP-1 peptides
